Screener
Rigel Pharmaceuticals RIGL Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | As of / March 31, 2026 | As of / December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Deferred income tax asset | 243,279 | 245,852 |
| Operating lease right-of-use assets | 785 | 920 |
| Other assets | 2,357 | 1,908 |
| Total assets | $504,608 | $513,594 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $4,486 | $7,191 |
| Accrued compensation | 6,009 | 11,914 |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's total assets?
- Rigel Pharmaceuticals (RIGL) reported total assets of $504.61M in Q1 2026.
- How has Rigel Pharmaceuticals's total assets changed year-over-year?
- Rigel Pharmaceuticals's total assets increased by 186.8% year-over-year, from $175.97M to $504.61M.
- What is the long-term trend for Rigel Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's total assets has grown at a 36.0% compound annual growth rate (CAGR), from $110.38M to $513.59M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Rigel Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude